Fresh Tracks Therapeutics, Inc. (FRTX)

Fresh Tracks Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	10.87	8.68	26.88	30.12	7.23
Short-Term Investments	-	-	-	-	4.5
Cash & Short-Term Investments	10.87	8.68	26.88	30.12	11.73
Cash Growth	25.21%	-67.71%	-10.73%	156.76%	45.39%
Receivables	0.05	0.5	0.13	-	-
Prepaid Expenses	0.55	0.52	1.09	3.42	6.24
Other Current Assets	0.09	0.38	1.5	-	-
Total Current Assets	11.55	10.08	29.6	33.53	17.97
Property, Plant & Equipment	0.03	0.12	0.12	0.1	0.18
Long-Term Accounts Receivable	-	0.06	-	-	-
Total Assets	11.59	10.27	29.72	33.63	18.14
Accounts Payable	0.41	0.57	1.61	0.57	2.25
Accrued Expenses	1.25	2.46	3.14	5.42	6.38
Current Portion of Long-Term Debt	-	-	-	0.29	-
Current Portion of Leases	-	0.05	0.07	0.07	0.08
Current Unearned Revenue	-	-	-	-	1.8
Total Current Liabilities	1.66	3.08	4.81	6.35	10.5
Long-Term Debt	-	-	-	0.15	-
Long-Term Leases	-	-	-	-	0.07
Total Liabilities	1.66	3.08	4.81	6.5	10.57
Common Stock	0.06	0.03	0.03	0.54	0.09
Additional Paid-In Capital	182.03	173.63	170.25	132.49	92.5
Retained Earnings	-172.16	-166.47	-145.37	-105.89	-84.98
Comprehensive Income & Other	-	-	-	-	-0.03
Total Common Equity	9.93	7.19	24.91	27.14	7.57
Shareholders' Equity	9.93	7.19	24.91	27.14	7.57
Total Liabilities & Equity	11.59	10.27	29.72	33.63	18.14
Total Debt	-	0.05	0.07	0.51	0.15
Net Cash (Debt)	10.87	8.63	26.82	29.6	11.58
Net Cash Growth	25.92%	-67.81%	-9.42%	155.69%	237.75%
Net Cash Per Share	2.01	3.07	15.02	54.34	172.35
Filing Date Shares Outstanding	5.97	5.91	2.65	1.49	0.21
Total Common Shares Outstanding	5.97	3.02	2.65	1.19	0.19
Working Capital	9.9	7.01	24.79	27.18	7.47
Book Value Per Share	1.66	2.38	9.39	22.80	40.19
Tangible Book Value	9.93	7.19	24.91	27.14	7.57
Tangible Book Value Per Share	1.66	2.38	9.39	22.80	40.19

Source: S&P Global Market Intelligence. Standard template. Financial Sources.